Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease?

No Comments
| News

We are excited to announce a new publication by Dr. Anna Onisiforou, head of our AI and Systems Bioinformatics Unit Cyprus, published in Open Forum Infectious Diseases. This review paper, titled “The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease?”, raises a fundamental question about […]

Read More »

New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis

No Comments
| News

Climate change accelerates the breakdown of plastics, increasing our exposure to microplastic-derived compounds, including bisphenols and phthalates, that act as xenoestrogens capable of disrupting hormonal and immune regulation. Separately, Epstein–Barr virus (EBV), which infects over 95% of adults worldwide and persists silently in immune cells, has been increasingly implicated in the development of both Alzheimer’s […]

Read More »

New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms

No Comments
| News

We are excited to share our new publication in Neuroscience and Biobehavioral Reviews. This is the first review to systematically compare the neurobiological underpinnings of misophonia and tinnitus. These are two debilitating auditory conditions that exact a significant toll on social functioning and mental health. Although often studied in isolation, both disorders share striking neurobiological […]

Read More »

Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal

No Comments
| News

We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been appointed as an Editorial Board Member of Neuropharmacology, one of the leading journals in the field of neuroscience and pharmacology. Neuropharmacology, published by Elsevier, is a premier international journal that publishes high-impact research on the effects of drugs on […]

Read More »

Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine

No Comments
| News

The Zanos Lab is pleased to announce the publication of a short review article in the Disease of the Month series of Trends in Molecular Medicine. The article, titled “Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapies,” is authored by Dr. Anna Onisiforou, Mr. Morfeas Koumas, and the lab director, Dr. Panos Zanos. This […]

Read More »

Dr. Zanos appointed as science communication coordinator for European psychedelics research network

No Comments
| News

We are pleased to announce that Dr. Zanos has been appointed as Science Communication Coordinator for COST Action CA24130, titled “Psychedelic renaissance: turn on, tune in and drop in” (PSY-NET). This European research network brings together scientists, clinicians, industry partners, and regulatory bodies to advance research on psychedelics for therapeutic applications. Dr. Zanos’ appointment to […]

Read More »

Dr. Anna Onisiforou secures €100,000 ERC Vision funding for Multiple Sclerosis research

No Comments
| News

We are pleased to announce that Dr. Anna Onisiforou, Senior Scientist and Head of the AI & Systems Bioinformatics Unit of our lab, has secured €100,000 in funding through the ERC Vision program of the Research and Innovation Foundation of Cyprus. This outstanding achievement recognizes Dr. Onisiforou’s innovative research and her leadership in developing computational […]

Read More »

Zanos Lab research on ketamine’s therapeutic mechanisms in depression and Opioid Use Disorder was presented in a seminar at the University of Haifa

No Comments
| News

The Zanos Lab presented research on the neurobiological mechanisms underlying ketamine’s efficacy in treating both depression and substance use disorders. Dr. Zanos, Director of the Translational Neuropharmacology Lab, delivered a talk detailing the lab’s multifaceted approach to understanding how ketamine and its metabolites can address two of the most pressing public health challenges of our […]

Read More »

Our Ph.D. student, Despina Melanthiou, featured in national newspaper article on Misophonia research

No Comments
| News

We are pleased to announce that Despina Melanthiou, a PhD student in the Zanos Lab, was featured in an article published in Politis newspaper on December 14, 2025, discussing her research on misophonia and its neurological underpinnings. The article, titled “When Everyday Sounds Become Pathologically Unbearable,” explores misophonia as a neurological condition that affects approximately […]

Read More »

Our Ph.D. student Morfeas Koumas authors public article on Opioid Use Disorder

No Comments
| News

We’re pleased to share that Morfeas Koumas, PhD student in the Zanos Lab, has published an article in Neolaia (Youth), a Cyprus-based journal, as part of the dissemination efforts for our PROUD study. The article, titled “Opioid Use Disorder: A Growing Public Health Challenge,” provides an accessible overview of opioid use disorder and discusses emerging therapeutic approaches, […]

Read More »

Posts pagination

1 2 … 13 Next

Recent Posts

  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026
  • New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis February 24, 2026
  • New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms January 29, 2026
  • Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal January 17, 2026
  • Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine January 4, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress